TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Average daily Step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MET's of Self-reported physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teeth vitality test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall hand grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: pinch grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: upper limb function for activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Electrogustometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sniffing Stick Smell Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strips' Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste and Smell Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of self-administration of Elranatamab
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Volume of DRG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fractional anisotropy of DRG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in snakebite severity score (SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2h-plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients achieving at least 90% improvement of rash
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Feasibility measured by the technology acceptance measure (TAM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gastric contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length of lumbar cone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Width of subarachnoid space
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants with Changes in liver function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: change in cervical proprioception
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decline of renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Numeric rating scale pain score at movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot and Ankle Outcomes Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neck Pain and Disability scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean change in the Insomnia Severity Index (ISI) total score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in Pressure Pain Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in lumbar spine flexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurofilament light chain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Vital Signs: Systolic and Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Participants' HPV vaccine uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants with Inherited Cardiomyopathy Syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants with Inherited Arrhythmia Syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants with Adverse Structural and Electrophysiologic Changes to the Atria and Ventricles for Inherited Cardiomyopathy Syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants with Adverse Structural and Electrophysiologic Changes to the Atria and Ventricles for Inherited Arrhythmia Syndromes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants who completed the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of exercise visits attended per participant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of RIC home applications completed per participant
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intervention Acceptability Questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in conformality index of tumor target volume delineation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PET scan standardized uptake value (SUV) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache days - severe and moderate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posthepatectomy liver failure
Endpoint domain: Adverse events/effects
Primary endpoint: Posthepatectomy biliary leakage
Endpoint domain: Adverse events/effects
Primary endpoint: Posthepatectomy hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Incontinence episodes (positive response rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in plasma tHcy levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of mature oocytes (MIIs) retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Recommended Phase 2 Dose (RP2D) of SR-8541A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-COVID-19 Functional Status scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diagnostic accuracy for ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding leading to hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients with clinical improvement on the ONLS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: T1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basic audiological evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Auditory evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on vestibular functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin insulin sensitivity: ratio of phosphorylated to total AKT in skin biopsies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fasting serum insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Fasting serum C-peptide level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Atypical shape of lateralized readiness potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of participants completing planned radiation therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Isometric trunk flexor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Isometric trunk extension strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Isometric trunk lateral flexion strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in the Intraocular Pressure (mmHg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants With Ocular and Non-ocular AEs (Adverse Events) and SAEs (Serious Adverse Events)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in CSF Neurofilament Light Chain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Caregiver Assisted Transfer Technique Instrument (CATT) Scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intent to be vaccinated against Covid-19
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Cognitive state in 1 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline thermic effect of food in kcal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rolland Morris Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Owestry Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Analogue visual score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caregivers' recommendations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Classroom Engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Wellbeing / wellness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptability of enrollment and randomization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Relapse of infection
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of appropriate empirical antibiotic therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Bone Signal Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average tracking accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-segment late lumen loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change from baseline in forced expiratory volume in 1 second (FEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in the Gold score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary school final examination test grades
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Obtained high school degree
Endpoint domain: Life impact
Endpoint subdomain: Educational outcomes
Primary endpoint: Obtained university degree
Endpoint domain: Life impact
Endpoint subdomain: Educational outcomes
Primary endpoint: Opioid Related Adverse Events (RD)
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid Related Adverse Events (PONV)
Endpoint domain: Adverse events/effects
Primary endpoint: Opioid Related Adverse Events (Excessive Sedation)
Endpoint domain: Adverse events/effects
Primary endpoint: Uncontrolled severe pain
Endpoint domain: Adverse events/effects
Primary endpoint: Partial arterial pressure in oxygen over inspired fraction of oxygen (PaO2/FiO2) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sensation and voluntary control of the ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival phenotype prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of target sample recruited within 6 months
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants retained at follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Qualitative acceptability of the intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HDL (Lipidic profile)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Arterial Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Queen College Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Physical functioning
Primary endpoint: Duration of conjunctival swelling/hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of pulmonary vein isolation techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 3h-iAUC of PPGR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Interval between induction to complete abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient compliance of performing medical examination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient compliance of taking medication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lesion detection ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients completing treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reliability of the Turkish version of Pain Modulation Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of the Turkish version of Pain Modulation Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with BPAR presenting Low Sensitivity to immunosuppressive drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acceptance of the overall performance of the IV catheter system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline bone mineral density (BMD) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and mineral outcomes
Primary endpoint: Change from baseline bone mineral contents (BMC) at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and mineral outcomes
Primary endpoint: Change from baseline of bone-specific alkaline phosphatase at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and mineral outcomes
Primary endpoint: General knowledge of women about Gestational Diabetes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: hallux valgus angle (HVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intermetatarsal angle (IMA) 1-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual analogue scale (VAS) for pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effectiveness of motion management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percent Change From Baseline in Intraocular Pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Difference in concentration of MCP-1 in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in concentration of MCP-1 in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Difference in concentration of MCP-1 in synovial fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: BIS and NOL values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in expression of CXCL9, CXCL10, and IFN-γ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Formaldehyde-DNA adducts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative DNA adduct 8-oxo-dG in DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary NNN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NNN-derived HPB-releasing DNA adducts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: portal vein flow velocity (cm/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: inferior vena cava diameter (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: hepatic vein flow velocity (cm/s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean diastolic and systolic perfusion pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proteins intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Differences in virus-specific antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Differences in cytokine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Differences in immune cell composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Differences in molecular immune cell makeup
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Resolution of DKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Length of stay in the medical intensive care unit (in days)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Symptomatic remission
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Injurious falls resulting in healthcare utilization
Endpoint domain: Adverse events/effects
Primary endpoint: Daily calorie attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Daily protein attainment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in radiographically progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients receiving SBIRT
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean Total Blood Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Successful home-based therapeutic drug monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Micro-wave ablation area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Gingival health (gingival index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgery complications
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with antiviral therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Number of participants with significant liver histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Shock control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBV DNA viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Course Interest Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient experience questionnaire-15
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Morinski-Green Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: global aesthetic scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants who successfully complete the focus group
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Exceptional Survival
Endpoint domain: Mortality/survival
Primary endpoint: Change of Pelvic floor muscle contraction during Valsalva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of acute pain (EVENDOL Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of acute pain (VAS Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cumulative Loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Multi-Domain Biomechanics during Tasks of Increasing Biomechanical Demand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of the treatment at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in unmedicated intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Dosimetry (D90)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Stroke and Systemic Embolic Events (SEE)
Endpoint domain: Mortality/survival
Primary endpoint: Number of PLWH with unsolicited adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Serum Immunoglobulin (IgG) antibody levels expressed as geometric mean enzyme-linked immunosorbent assay units (GMEU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Human angiotensin-converting enzyme 2 (hACE2) receptor binding inhibition assay expressed as geometric mean titer (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes